Monday, November 21, 2016

BRIEF-Biophytis receives authorizations to conduct SARA-OBS study in sarcopenia patients

* Biophytis received regulatory authorizations to conduct SARA-OBS study in sarcopenia

patients

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)